Novartis poaches Pfizer veteran Liz Barrett to lead cancer unit—and its big Kymriah and Kisqali rollouts

11th January 2018 Uncategorised 0

Novartis brought on Pfizer executive Liz Barrett to head up its oncology outfit after Bruno Strigini’s retirement. One of her signature accomplishments: The rollout of Ibrance, a breast cancer drug among Pfizer’s biggest recent successes—and a head-to-head competitor to Novartis’ own Kisqali.

More: Novartis poaches Pfizer veteran Liz Barrett to lead cancer unit—and its big Kymriah and Kisqali rollouts
Source: fierce